Andreas Rosenwald Selected Research

DNA (Deoxyribonucleic Acid)

1/2023	Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis.
10/2021	In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin's lymphoma and facilitates ultrasensitive residual disease detection.
1/2021	Presence of Parvovirus B19 but Not Herpesvirus Genome in Acute Skin Rash after Allogeneic Stem Cell Transplantation Correlates with Outcome.
1/2019	Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in diffuse large B cell lymphoma.
1/2019	The identification of patient-specific mutations reveals dual pathway activation in most patients with melanoma and activated receptor tyrosine kinases in BRAF/NRAS wild-type melanomas.
9/2015	Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.
5/2013	p53 DNA binding cooperativity is essential for apoptosis and tumor suppression in vivo.
1/2013	Characterization of the p53 cistrome--DNA binding cooperativity dissects p53's tumor suppressor functions.
1/2011	Epigenetic activation of SOX11 in lymphoid neoplasms by histone modifications.
10/2010	A multiplex MALDI-TOF MS approach facilitates genotyping of DNA from formalin-fixed paraffin-embedded tumour specimens.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreas Rosenwald Research Topics

Disease

130	Neoplasms (Cancer) 05/2024 - 04/2002
58	Lymphoma (Lymphomas) 11/2023 - 12/2003
48	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 06/2002
33	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2022 - 11/2005
32	B-Cell Lymphoma (Lymphoma, B Cell) 02/2024 - 12/2002
22	Multiple Myeloma 01/2023 - 01/2012
18	Disease Progression 11/2023 - 09/2004
18	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2021 - 05/2002
15	Hodgkin Disease (Hodgkin's Disease) 10/2023 - 11/2004
14	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2023 - 06/2003
14	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2023 - 06/2006
12	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2021 - 04/2002
11	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 06/2009
8	Neoplasm Metastasis (Metastasis) 02/2023 - 01/2012
8	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2016 - 06/2003
7	Carcinogenesis 04/2022 - 04/2009
6	Inflammation (Inflammations) 07/2023 - 10/2010
6	Infections 12/2022 - 06/2003
6	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 08/2010
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 01/2015
6	Genetic Translocation (Chromosomal Translocation) 12/2016 - 12/2002
5	Carcinoma (Carcinomatosis) 09/2023 - 08/2004
5	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 11/2021 - 06/2009
5	Adrenocortical Carcinoma 12/2018 - 11/2015
4	Breast Neoplasms (Breast Cancer) 02/2023 - 03/2008
4	Leukemia 05/2017 - 06/2004
3	Adenoma (Adenomas) 01/2022 - 03/2012
3	Melanoma (Melanoma, Malignant) 01/2019 - 08/2013
2	Paraganglioma (Paragangliomas) 11/2023 - 01/2022
2	Fibrosis (Cirrhosis) 07/2023 - 12/2008
2	Squamous Cell Carcinoma of Head and Neck 01/2023 - 10/2016
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 07/2015
2	Colitis 01/2023 - 07/2015

Drug/Important Bio-Agent (IBA)

41	Proteins (Proteins, Gene)FDA Link 12/2022 - 04/2002
23	Rituximab (Mabthera)FDA Link 02/2024 - 01/2011
21	Biomarkers (Surrogate Marker)IBA 06/2023 - 07/2006
18	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 06/2002
16	Vincristine (Oncovin)FDA LinkGeneric 02/2024 - 12/2011
15	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2024 - 12/2011
15	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2024 - 12/2011
15	RNA (Ribonucleic Acid)IBA 12/2022 - 05/2005
14	ParaffinIBA 11/2017 - 10/2008
13	Prednisone (Sone)FDA LinkGeneric 02/2024 - 12/2011
12	AntigensIBA 11/2023 - 05/2002
12	MicroRNAs (MicroRNA)IBA 12/2022 - 09/2008
12	Messenger RNA (mRNA)IBA 11/2021 - 02/2003
12	Phosphotransferases (Kinase)IBA 01/2020 - 09/2005
11	Cyclin D1IBA 01/2021 - 02/2003
11	Formaldehyde (Formol)FDA Link 11/2017 - 10/2008
9	AntibodiesIBA 01/2022 - 04/2009
8	ibrutinibIBA 12/2022 - 09/2014
7	CyclinsIBA 01/2021 - 12/2005
7	Protein Isoforms (Isoforms)IBA 02/2017 - 06/2007
7	Complementary DNA (cDNA)IBA 01/2013 - 07/2003
7	NF-kappa B (NF-kB)IBA 05/2008 - 12/2002
6	Chemokine ReceptorsIBA 12/2023 - 04/2015
6	68Ga-pentixaforIBA 12/2023 - 11/2017
6	Etoposide (VP 16)FDA LinkGeneric 01/2023 - 11/2011
6	CytokinesIBA 01/2023 - 02/2003
6	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 10/2021 - 06/2003
6	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 12/2002
6	Immunoglobulin M (IgM)IBA 01/2019 - 04/2004
6	Anaplastic Lymphoma KinaseIBA 05/2014 - 04/2002
5	Keratins (Keratin)IBA 09/2023 - 01/2012
5	Methotrexate (Mexate)FDA LinkGeneric 01/2023 - 10/2013
5	carboxyl radical (COO-)IBA 09/2018 - 06/2011
4	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 11/2011
4	Monoclonal AntibodiesIBA 01/2021 - 08/2013
4	LigandsIBA 01/2021 - 11/2005
4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 11/2011
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2019 - 11/2004
3	Chimeric Antigen ReceptorsIBA 05/2024 - 01/2023
3	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2023 - 01/2021
3	Prednisolone (Predate)FDA LinkGeneric 12/2022 - 09/2018
3	Mitogen-Activated Protein KinasesIBA 05/2022 - 10/2010
3	Lenalidomide (CC 5013)FDA Link 01/2021 - 09/2016
3	AutoantigensIBA 01/2021 - 11/2015
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2020 - 07/2007
3	Peptides (Polypeptides)IBA 01/2020 - 11/2013
3	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2019 - 03/2009
3	ChemokinesIBA 10/2018 - 03/2009
3	Glucose (Dextrose)FDA LinkGeneric 09/2016 - 08/2013
3	Bortezomib (Velcade)FDA Link 09/2016 - 03/2009
3	Endoplasmic Reticulum Chaperone BiPIBA 09/2016 - 01/2013
3	Transcription Factors (Transcription Factor)IBA 09/2015 - 05/2005
3	Cisplatin (Platino)FDA LinkGeneric 01/2014 - 03/2008
3	Tyrosine (L-Tyrosine)FDA Link 01/2013 - 12/2010
3	Cyclin D2IBA 11/2009 - 02/2004
3	Indicators and Reagents (Reagents)IBA 01/2007 - 12/2005
2	Bleomycin (Blenoxane)FDA LinkGeneric 07/2023 - 11/2019
2	NucleotidesIBA 01/2023 - 01/2019

Therapy/Procedure

61	Therapeutics 12/2023 - 02/2003
16	Drug Therapy (Chemotherapy) 04/2021 - 06/2002
9	Immunotherapy 05/2024 - 01/2013
9	Stem Cell Transplantation 01/2023 - 11/2011
5	Radiotherapy 10/2023 - 11/2019
4	Aftercare (After-Treatment) 10/2021 - 05/2017
3	Precision Medicine 11/2022 - 11/2017
3	Cell Transplantation 01/2021 - 01/2013
3	Salvage Therapy 01/2020 - 11/2011